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ABSTRACT 
According to Article 12 of Regulation (EC) No 396/2005, the European Food Safety Authority (EFSA) has 
reviewed the Maximum Residue Levels (MRLs) currently established at European level for the pesticide active 
substance warfarin. Considering that this active substance is not authorised for use on edible crops within the 
European Union, that no MRLs are established by the Codex Alimentarius Commission, and that no import 
tolerances were notified to EFSA, residues of warfarin are not expected to occur in any plant or animal 
commodity. Available data were also not sufficient to derive a residue definition or an LOQ for enforcement 
against potential illegal uses. 
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SUMMARY 
Warfarin was included in Annex I to Directive 91/414/EEC on 01 October 2006, which is before the 
entry into force of Regulation (EC) No 396/2005 on 02 September 2008. EFSA is therefore required to 
provide a reasoned opinion on the review of the existing MRLs for that active substance in compliance 
with Article 12(2) of afore mentioned regulation. In order to collect the relevant pesticide residues 
data, EFSA asked Ireland, as the designated rapporteur Member State (RMS), to complete the 
Pesticide Residues Overview File (PROFile). An evaluation report was submitted on 21 October 2009 
confirming that the pesticide use of warfarin is not intended for direct application on any food or feed 
crop and that no import tolerances for this active substance were notified to the RMS. Submission of a 
PROFile was therefore not considered relevant. EFSA therefore mainly based its assessment on the 
conclusions derived in the framework of Directive 91/414/EEC. 
On 12 December 2012, EFSA issued a draft reasoned opinion that was circulated to Member State 
experts for consultation. No comments were received by 15 February 2013 and the following 
conclusions are derived. 
Residues of warfarin are not expected to occur in any plant commodity or in any animal product 
because the pesticide use of warfarin is not intended for direct application on any food or feed crop, no 
CXLs are available for this active substance and no uses authorised in third countries were notified to 
the RMS. A risk assessment is therefore in principle not required. Due to the lack of data regarding 
mammalian toxicology, plant and livestock metabolism and analytical methods for enforcement of 
residues, EFSA is however not in a position to recommend any enforcement measure against the 
potential illegal use of warfarin. It is also not possible to verify whether the default MRL of 0.01 
mg/kg, as defined by Regulation (EC) No 396/2005, provides sufficient consumer protection in case 
of misuse. 
As sufficient information was available to demonstrate that warfarin is highly toxic to mammals on 
repeated ingestion, the compound is in any case not recommended for inclusion in Annex IV to the 
above regulation. EFSA also recommends that adequate restrictions are being imposed on the 
authorised products by Member States in order to avoid contamination of the food and feed crops 
being stored. Review of the existing MRLs for warfarin
 
EFSA Journal 2013;11(2):3124  3
TABLE OF CONTENTS 
Abstract .................................................................................................................................................... 1 
Summary .................................................................................................................................................. 2 
Table of contents ...................................................................................................................................... 3 
Background .............................................................................................................................................. 3 
Terms of reference .................................................................................................................................... 4 
The active substance and its use pattern ................................................................................................... 4 
Assessment ............................................................................................................................................... 5 
Conclusions and recommendations .......................................................................................................... 5 
References ................................................................................................................................................ 6 
Appendix – Good Agricultural Practices (GAPs) .................................................................................... 7 
Abbreviations ........................................................................................................................................... 8 
 
BACKGROUND 
Regulation (EC) No 396/2005
4 establishes the rules governing the setting as well as the review of 
pesticide MRLs at European level. Article 12(2) of that regulation lays down that EFSA shall provide 
by 01 September 2009 a reasoned opinion on the review of the existing MRLs for all active substances 
included in Annex I to Directive 91/414/EEC
5 before 02 September 2008. As warfarin was included in 
Annex I to the above mentioned directive on 01 October 2006, EFSA initiated the review of all 
existing MRLs for that active substance and a task with the reference number EFSA-Q-2008-647 was 
included in the EFSA Register of Questions. 
According to the legal provisions, EFSA shall base its reasoned opinion in particular on the relevant 
assessment report prepared under Directive 91/414/EEC. It should be noted, however, that in the 
framework of Directive 91/414/EEC only a few representative uses are evaluated while MRLs set out 
in Regulation (EC) No 396/2005 should accommodate for all uses authorised within the EU as well as 
uses authorised in third countries having a significant impact on international trade. The information 
included in the assessment report prepared under Directive 91/414/EEC is therefore insufficient for the 
assessment of all existing MRLs for a given active substance. 
In order to have an overview of the pesticide residues data that have been considered for the setting of 
the existing MRLs, EFSA developed the Pesticide Residues Overview File (PROFile). The PROFile is 
an electronic inventory of all pesticide residues data relevant to the risk assessment as well as the MRL 
setting for a given active substance. This includes data on: 
•  the nature and magnitude of residues in primary crops; 
•  the nature and magnitude of residues in processed commodities;  
•  the nature and magnitude of residues in rotational crops;  
•  the nature and magnitude of residues in livestock commodities and;  
•  the analytical methods for enforcement of the proposed MRLs. 
Ireland, the designated rapporteur Member State (RMS) in the framework of Directive 91/414/EEC, 
was asked to complete the PROFile for warfarin. Nevertheless, an evaluation report was submitted on 
21 October 2009 confirming that the pesticide use of warfarin is not intended for direct application on 
                                                      
4 Commission Regulation (EC) No 396/2005 of 23 February 2005. OJ L 70, 16.3.2005, p. 1-16. 
5 Council Directive 91/414/EEC of 15 July 1991, OJ L 230, 19.8.1991, p. 1-32. Review of the existing MRLs for warfarin
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any food or feed crop and that no import tolerances for this active substance were notified to the RMS. 
Submission of a PROFile was therefore not considered relevant. 
A draft reasoned opinion was issued by EFSA on 12 December 2012 and submitted to Member States 
(MS) for commenting. No comments were received by 15 February 2013. 
TERMS OF REFERENCE 
According to Article 12 of Regulation (EC) No 396/2005, EFSA shall provide a reasoned opinion on: 
•  the inclusion of the active substance in Annex IV to the Regulation, when appropriate; 
•  the necessity of setting new MRLs for the active substance or deleting/modifying existing MRLs 
set out in Annex II or III of the Regulation; 
•  the inclusion of the recommended MRLs in Annex II or III to the Regulation; 
•  the setting of specific processing factors as referred to in Article 20(2) of the Regulation. 
 
THE ACTIVE SUBSTANCE AND ITS USE PATTERN 
Warfarin is the ISO common name for 4-hydroxy-3-[(1RS)-3-oxo-1-phenylbutyl]coumarin or (RS)-3-
(α-acetonylbenzyl)-4-hydroxycoumarin (IUPAC). 
O O
OH
CH CH2C CH3
O
 
Warfarin belongs to the group of coumarin compounds which are used as rodenticide. Warfarin and 
warfarin sodium salt are systemic compounds which both act as anticoagulants; these are highly toxic 
to mammals on repeated ingestion, but of lesser, variable toxicity to different species when given as a 
single oral dose. In fact, warfarin inhibits the formation of prothrombin by replacing Vitamin K in the 
complex, and this reduces the clotting capacity of blood, as well as increasing capillary permeability. 
Warfarin was evaluated in the framework of Directive 91/414/EEC with Ireland being the designated 
rapporteur Member State (RMS). The representative uses supported for the peer review process were a 
storage protection treatment against rats and the protection of trees in the woodland areas against grey 
squirrel. Following the peer review, a decision on inclusion of the active substance in Annex I to 
Directive 91/414/EEC was published by means of Commission Directive 2006/5/EC
6, which entered 
into force on 01 October 2006. According to Regulation (EU) No 540/2011
7, warfarin is deemed to 
have been approved under Regulation (EC) No 1107/2009
8 as well. This approval is restricted to uses 
as rodenticide only. As EFSA was not yet involved in the peer review of warfarin, an EFSA 
Conclusion on this active substance is not available. 
                                                      
6 Directive 2006/5/EC of 17 January 2006, OJ L 12, 18.1.2006, p. 17-20. 
7 Regulation (EU) No 540/2011 of 25 May 2011, OJ L 153, 11.6.2011, p. 1-186. 
8 Regulation (EC) No 1107/2009 of 21 October 2009, OJ 309, 24.11.2009, p. 1–50. Review of the existing MRLs for warfarin
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No MRLs are currently set for warfarin; hence the default MRL of 0.01 mg/kg applies (according to 
art. 18, 1, b of Regulation (EC) No 396/2005). CXLs for warfarin are also not available. 
Warfarin is registered for use on stored products and forestry/amenity within the European Union (see 
Appendix A) and the RMS did not report any use authorised in third countries that might have a 
significant impact on international trade.  
ASSESSMENT 
Considering that the use of warfarin is only authorised within the EU on forestry and amenity (non-
consumable crops) and on stored products (where no contact with food or feed is expected), that no 
CXLs are available for this active substance and that no uses authorised in third countries were 
notified to the RMS, European consumers are not expected to be exposed to residues of this active 
substance and a consumer risk assessment is, in principle, not required. Risk managers might have 
interest, however, to enforce against the potential illegal use of warfarin within the EU as well as the 
presence of illegitimate residue levels in imported products. In order to assist risk managers in 
applying the most appropriate enforcement measures, EFSA assessed the available data with particular 
attention for the analytical methods, the toxicological reference values and the nature of residues in 
plants and livestock. The assessment of EFSA is mainly based on the Draft Assessment Report (DAR) 
prepared under Council Directive 91/414/EEC (Ireland, 2002) as well as the Review Report on 
warfarin (EC, 2004). The evaluation report submitted by the RMS in the framework of this review 
(Ireland, 2009) was considered as additional supporting information. 
The toxicological assessment of warfarin was peer reviewed under Directive 91/414/EEC but no 
toxicological reference values have been proposed due to the lack of information. Warfarin is known 
to be highly toxic to mammals through its mode of action; nevertheless, further information was not 
considered necessary as direct application on crops is not intended.  
Under the peer review of Directive 91/414/EEC, no analytical methods for enforcement of warfarin in 
commodities of plant and animal origin were available and no residue data were provided because 
direct application on crops is not intended. Nevertheless, contamination cannot be excluded according 
to EFSA; Member States should therefore ensure that adequate restrictions are being imposed on the 
authorised products in order to avoid contamination of the food and feed crops being stored. 
Consequently, EFSA is not in a position to recommend any enforcement measure against the potential 
contamination of stored crops and due to lack of data on toxicology of the compound, it is also not 
possible to assess whether the default MRL of 0.01 mg/kg, as defined by Regulation (EC) No 
396/2005, would provide adequate consumer protection in case of misuse. 
CONCLUSIONS AND RECOMMENDATIONS 
Residues of warfarin are not expected to occur in any plant commodity or in any animal product 
because the pesticide use of warfarin is not intended for direct application on any food or feed crop, no 
CXLs are available for this active substance and no uses authorised in third countries were notified to 
the RMS. A risk assessment is therefore in principle not required. Due to the lack of data regarding 
mammalian toxicology, plant and livestock metabolism and analytical methods for enforcement of 
residues, EFSA is however not in a position to recommend any enforcement measure against the 
potential illegal use of warfarin. It is also not possible to verify whether the default MRL of 0.01 
mg/kg, as defined by Regulation (EC) No 396/2005, provides sufficient consumer protection in case 
of misuse. 
As sufficient information was available to demonstrate that warfarin is highly toxic to mammals on 
repeated ingestion, the compound is in any case not recommended for inclusion in Annex IV to the 
above regulation. EFSA also recommends that adequate restrictions are being imposed on the Review of the existing MRLs for warfarin
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authorised products by Member States in order to avoid contamination of the food and feed crops 
being stored. 
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APPENDIX – GOOD AGRICULTURAL PRACTICES (GAPS) 
 
Crop and/ 
or situation 
Member 
State or 
Country 
Product 
name 
F 
G 
or I 
Pests or 
Group of 
Pests 
controlled 
 
 
Formulation 
 
 
Application 
 
 
Application rate per treatment 
PHI 
(days) 
 
 
 
 
(a) 
    
 
(b) 
 
 
(c) 
Type 
 
(d) 
Conc. 
of as 
 
 
Method 
kind 
 
 
Growth 
stage & 
season 
 
Number 
min  max 
 
 
Interval 
between 
appls. 
(min) 
kg 
as/hL 
min  
max 
Water 
L/ha 
min  max 
kg 
as/ha 
min  
max 
 
Storage 
protection 
Germany Curattin 
Haftstreu-
puder 
F Rattus 
norvegicus 
CB  0.49%  It is recommended to mix the product with 
suitable bait. Effective baits are meat and fish 
scraps or cereal products. Poisoned baits are 
placed in rat holes and/or laid out in bait 
stations near their paths using a small shovel 
without requiring further equipment. 
Lay out frequently as long as acceptance is 
observed 
It is recommended to mix the 
product with suitable bait in a 
ratio of 1:10. This will lead to 
a final concentration of 0.49g 
of Warfarin per kg of bait. 
Lay out in portions of 250g 
per bait location (approx. 125 
mg a.s.) 
 N.A. 
Storage 
protection 
Germany Curattin 
Haftstreu-
puder 
I Rattus 
norvegicus 
TP  0.49%  The ready-to-use product is strewn into rat 
holes or onto their tracking paths (indoor use) 
manually (wearing protective gloves) with the 
aid of a small shovel or a simple application 
device. Re-apply frequently until no further 
traces are visible. 
Approx. 30g preparation per 
rat hole, and on tracking paths 
(approx. 150 mg a.s.) 
N.A. 
Storage 
protection 
Germany Cumarax 
Rattenring 
F Rattus 
norvegicus 
BB  0.04%  Cumarax Rattenring is a ready-to-use solid, 
ring-formed bait for protection from rats of 
harvested crops, elimination of rats in sewers, 
along ditches and brooks and in houses. The 
rings must be laid out by hand near hiding 
places or tracks of rats. New rings must be 
laid out after 1-2 days approx. until 
elimination of the rats 
Each ring (250g) contains 
100mg warfarin. 
Ditches and brooks: 1ring for 
50m. (approx.) bank. 
Sewage: 1-3 rings per shaft. 
Domestic use: 1 ring per 10 
animals (100 mg a.s.).  
N.A. 
Storage 
protection 
Luxem-
burg 
Cumarax 
Rattenring 
F Rattus 
norvegicus 
BB 0.04%  N.A. 
Storage 
protection 
Nether-
lands 
Cumarax 
Rattenring 
F Rattus 
norvegicus 
BB 0.04%  N.A. 
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ABBREVIATIONS 
ADI  acceptable daily intake 
ARfD  acute reference dose 
CXL  codex maximum residue limit 
DAR  Draft Assessment Report (prepared under Council Directive 91/414/EEC) 
EC European  Commission 
EFSA  European Food Safety Authority 
EU European  Union 
GAP  good agricultural practice 
ISO  International Organisation for Standardization 
IUPAC  International Union of Pure and Applied Chemistry 
LOQ  limit of quantification  
MRL  maximum residue limit 
MS Member  States 
PROFile  (EFSA) Pesticide Residues Overview File 
RA risk  assessment 
RD residue  definition 
RMS  rapporteur Member State 
 